$81.68
-0.13-0.16%
近くで: Dec 5, 4:00 PM EST
$81.97
0.290.35%
時間外: Dec 5, 5:35 PM EST
Comments
Loading...
インサイダー取引活動
最新の Ionis Pharmaceuticals インサイダー取引活動を追跡します。Ionis Pharmaceuticals 株の最近の購入、売却、市場への影響について最新情報を入手してください。
インサイダー活動とは何ですか?
インサイダー取引とは、役員、取締役、従業員などの企業内部関係者が自社の株式の取引を行う行為です。インサイダーの売買取引は、会社の将来の業績に対する彼らの信頼を知る貴重な洞察を提供します。
Ionis Pharmaceuticals Inc のインサイダーは何をしているのですか?
Ionis Pharmaceuticals Incでは、最近の内部関係者の活動が注目を集めています。過去 30 日間で、内部関係者は合計 28.00K 株相当の $2.26M 株を売却したと報告しています。過去 30 日間に購入がなかったと報告します。
最近の注目すべきインサイダー売買
- 10 8, 2025、Brett P Monia、会社の CHIEF EXECUTIVE OFFICER sold 437 株はそれぞれ $69.26 です。
- 10 8, 2025、Joseph Baroldi、会社の EVP, CHIEF BUSINESS OFFICER sold 1.63K 株はそれぞれ $69.37 です。
- 9 9, 2025、C. Frank Bennett、会社の EVP, CHIEF SCIENTIFIC OFFICER sold 6K 株はそれぞれ $59.6 です。
Ionis Pharmaceuticals Inc の所有権統計
発行済み株式数
161.974M
インサイダー所有株式数
1.413M
インサイダー保有率
0.87%
機関投資家保有株式
136.411M
機関投資家保有比率
84.2%
| Dec 03, 2025 | Joseph H Wender | DIRECTOR | -28.00K | $80.82 | -$2.26M | SELL | -34.98% | 52.03K | Dec 01 | View |
| Nov 28, 2025 | Joseph Klein, III | DIRECTOR | 0.00 | $80.00 | -$960.00K | SELL-OPTIONS | 0.00% | 100.00 | Nov 25 | View |
| Nov 28, 2025 | Shannon L Devers | EVP, CHIEF HUMAN RESOURCES OFC | 0.00 | $67.34 | -$455.34K | SELL-OPTIONS | 0.00% | 17.49K | Nov 25 | View |
| Nov 20, 2025 | Joan E Herman | DIRECTOR | 0.00 | $64.76 | -$648.43K | SELL-OPTIONS | 0.00% | 46.09K | Nov 19 | View |
| Nov 07, 2025 | Brian Birchler | EVP, CORP AND DEVELOPMENT OPS | -8.00K | $76.17 | -$609.38K | SELL | -14.08% | 48.83K | Nov 06 | View |
| Nov 07, 2025 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 0.00 | $67.37 | -$576.51K | SELL-OPTIONS | 0.00% | 59.66K | Nov 05 - Nov 06 | View |
| Nov 03, 2025 | Joseph H Wender | DIRECTOR | -28.00K | $74.02 | -$2.07M | SELL | -30.42% | 64.03K | Oct 30 - Oct 31 | View |
| Nov 03, 2025 | Joseph Loscalzo | DIRECTOR | 0.00 | $63.66 | -$366.15K | SELL-OPTIONS | 0.00% | 36.33K | Oct 31 | View |
| Nov 03, 2025 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | -20.00K | $66.97 | -$2.66M | SELL | -25.11% | 59.66K | Oct 31 - Nov 03 | View |
| Oct 16, 2025 | Eric Swayze | EVP RESEARCH | 72.00 | $73.62 | -$3.90K | SELL-OPTIONS | 0.24% | 30.71K | Oct 15 - Oct 16 | View |
| Oct 16, 2025 | B. Lynne Parshall | DIRECTOR | -5.00K | $71.74 | -$358.72K | SELL | -7.54% | 61.34K | Oct 15 | View |
| Oct 16, 2025 | Shannon L Devers | EVP, CHIEF HUMAN RESOURCES OFC | 1.56K | $60.79 | -$239.58K | SELL-OPTIONS | 9.77% | 17.49K | Oct 15 - Oct 16 | View |
| Oct 16, 2025 | Brian Birchler | EVP, CORP AND DEVELOPMENT OPS | 0.00 | $62.95 | -$438.88K | SELL-OPTIONS | 0.00% | 56.83K | Oct 14 - Oct 15 | View |
| Oct 08, 2025 | Eric Swayze | EVP RESEARCH | -6.85K | $69.02 | -$472.72K | SELL | -18.27% | 30.64K | Oct 06 | View |
| Oct 08, 2025 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | -3.24K | $61.30 | -$398.06K | SELL | -5.67% | 53.89K | Oct 06 | View |
| Oct 08, 2025 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -437.00 | $69.26 | -$30.27K | SELL | -0.24% | 179.57K | Oct 06 | View |
| Oct 08, 2025 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | -1.63K | $69.37 | -$112.73K | SELL | -4.64% | 33.37K | Oct 06 | View |
| Oct 02, 2025 | Joseph H Wender | DIRECTOR | -16.80K | $65.50 | -$1.10M | SELL | -15.44% | 92.03K | Oct 01 | View |
| Oct 02, 2025 | Eric Swayze | EVP RESEARCH | 0.00 | $59.96 | -$335.82K | SELL-OPTIONS | 0.00% | 37.49K | Oct 01 - Oct 02 | View |
| Oct 02, 2025 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 0.00 | $63.33 | -$563.80K | SELL-OPTIONS | 0.00% | 57.13K | Oct 02 | View |
| Oct 02, 2025 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 0.00 | $49.91 | -$543.21K | SELL-OPTIONS | 0.00% | 35.00K | Oct 02 | View |
| Oct 01, 2025 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 0.00 | $60.70 | -$198.39K | SELL-OPTIONS | 0.00% | 57.13K | Sep 29 - Sep 30 | View |
| Oct 01, 2025 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 0.00 | $59.51 | -$664.39K | SELL-OPTIONS | 0.00% | 79.66K | Sep 30 | View |
| Oct 01, 2025 | Elizabeth L Hougen | EVP, FINANCE & CFO | 0.00 | $59.51 | -$571.99K | SELL-OPTIONS | 0.00% | 110.50K | Sep 30 | View |
| Sep 16, 2025 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 0.00 | $60.68 | -$13.26K | SELL-OPTIONS | 0.00% | 57.13K | Sep 12 | View |
| Sep 11, 2025 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 0.00 | $46.98 | -$362.83K | SELL-OPTIONS | 0.00% | 35.00K | Sep 09 | View |
| Sep 11, 2025 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 0.00 | $62.62 | -$81.08K | SELL-OPTIONS | 0.00% | 57.13K | Sep 09 | View |
| Sep 09, 2025 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 0.00 | $46.90 | -$7.55K | SELL-OPTIONS | 0.00% | 35.00K | Sep 05 | View |
| Sep 09, 2025 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | -6.00K | $59.60 | -$357.58K | SELL | -6.77% | 82.68K | Sep 05 | View |
| Sep 04, 2025 | Eric Swayze | EVP RESEARCH | -11.13K | $49.67 | -$552.86K | SELL | -22.89% | 37.49K | Sep 02 | View |
| Sep 04, 2025 | Joseph H Wender | DIRECTOR | -28.00K | $57.58 | -$1.61M | SELL | -20.46% | 108.83K | Sep 02 - Sep 03 | View |
| Sep 04, 2025 | B. Lynne Parshall | DIRECTOR | -20.00K | $50.91 | -$1.02M | SELL | -23.16% | 66.34K | Sep 02 | View |
| Sep 04, 2025 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 0.00 | $52.32 | -$3.26M | SELL-OPTIONS | 0.00% | 180.01K | Sep 03 | View |
| Sep 04, 2025 | Joseph Klein, III | DIRECTOR | 0.00 | $60.00 | -$1.68M | SELL-OPTIONS | 0.00% | 100.00 | Sep 03 | View |
| Sep 04, 2025 | Joseph Klein, III | DIRECTOR | 0.00 | $60.00 | -$1.68M | SELL-OPTIONS | 0.00% | 100.00 | Sep 03 | View |
| Sep 04, 2025 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | -10.00K | $50.37 | -$503.67K | SELL | -11.15% | 79.66K | Sep 02 | View |
| Sep 04, 2025 | Shannon L Devers | EVP, CHIEF HUMAN RESOURCES OFC | 0.00 | $48.57 | -$78.74K | SELL-OPTIONS | 0.00% | 15.94K | Sep 03 | View |
| Sep 04, 2025 | Joseph H Wender | DIRECTOR | -28.00K | $57.58 | -$1.61M | SELL | -20.46% | 108.83K | Sep 02 - Sep 03 | View |
| Sep 04, 2025 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 0.00 | $45.57 | -$903.18K | SELL-OPTIONS | 0.00% | 35.00K | Sep 03 | View |
| Sep 04, 2025 | PATRICK ONEIL | EVP CLO & GENERAL COUNSEL | 0.00 | $52.57 | -$1.34M | SELL-OPTIONS | 0.00% | 57.13K | Sep 02 - Sep 03 | View |
| Sep 04, 2025 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | -5.00K | $56.75 | -$577.62K | SELL | -5.34% | 88.68K | Sep 02 - Sep 03 | View |
| Sep 04, 2025 | Joseph Loscalzo | DIRECTOR | 0.00 | $42.28 | -$571.65K | SELL-OPTIONS | 0.00% | 36.33K | Sep 03 | View |
| Sep 04, 2025 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 0.00 | $57.29 | -$138.41K | SELL-OPTIONS | 0.00% | 51.51K | Sep 03 | View |
| Aug 26, 2025 | Allene M Diaz | DIRECTOR | -1.43K | $42.53 | -$60.69K | SELL | -7.21% | 18.37K | Aug 22 | View |
| Aug 20, 2025 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $38.29 | -$113.78K | SELL-OPTIONS | 0.00% | 93.47K | Aug 18 | View |
| Aug 08, 2025 | B. Lynne Parshall | DIRECTOR | -5.00K | $41.93 | -$209.65K | SELL | -5.47% | 86.34K | Aug 06 | View |
| Aug 06, 2025 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | -10.00K | $42.86 | -$428.59K | SELL | -10.05% | 89.49K | Aug 05 | View |
| Aug 05, 2025 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | -9.55K | $42.80 | -$408.70K | SELL | -15.64% | 51.51K | Aug 04 | View |
| Aug 01, 2025 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 0.00 | $38.80 | -$30.16K | SELL-OPTIONS | 0.00% | 179.82K | Jul 30 | View |
| Jul 15, 2025 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -1.16K | $41.74 | -$48.42K | SELL | -0.64% | 179.82K | Jul 11 | View |
| May 02, 2025 | Michael R Hayden | DIRECTOR | 15.00K | $31.86 | $477.90K | BUY | 40.30% | 52.22K | May 01 | View |
| Apr 17, 2025 | Brian Birchler | EVP, CORP AND DEVELOPMENT OPS | 1.20K | $28.37 | -$19.29K | SELL-OPTIONS | 2.15% | 56.66K | Apr 15 - Apr 16 | View |
| Apr 17, 2025 | Kyle Jenne | EVP, CHF GL PDT STR OFCR | 9.21K | $28.36 | -$85.53K | SELL-OPTIONS | 463.05% | 11.20K | Apr 15 - Apr 16 | View |
| Apr 17, 2025 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 6.91K | $28.40 | -$111.56K | SELL-OPTIONS | 24.60% | 35.00K | Apr 15 - Apr 16 | View |
| Mar 13, 2025 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -140.00 | $32.32 | -$4.52K | SELL | -0.08% | 180.98K | Mar 11 | View |
| Feb 24, 2025 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | -1.21K | $32.35 | -$39.05K | SELL | -2.10% | 56.24K | Feb 20 | View |
| Feb 06, 2025 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | -6.17K | $31.62 | -$194.94K | SELL | -9.69% | 57.45K | Feb 04 | View |
| Feb 06, 2025 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -38.84K | $31.65 | -$1.23M | SELL | -17.69% | 180.68K | Feb 04 | View |
| Feb 03, 2025 | Eric Swayze | EVP RESEARCH | 2.35K | $32.31 | -$44.16K | GRANT | 5.12% | 48.20K | Jan 30 - Jan 31 | View |
| Feb 03, 2025 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 2.55K | $32.20 | -$47.78K | GRANT | 4.35% | 61.06K | Jan 30 - Jan 31 | View |
| Feb 03, 2025 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 2.41K | $32.49 | -$45.68K | GRANT | 3.94% | 63.62K | Jan 30 - Jan 31 | View |
| Feb 03, 2025 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 12.13K | $32.45 | -$429.66K | GRANT | 5.85% | 219.53K | Jan 30 - Jan 31 | View |
| Feb 03, 2025 | Elizabeth L Hougen | EVP, FINANCE & CFO | 2.62K | $32.44 | -$49.40K | GRANT | 2.42% | 110.50K | Jan 30 - Jan 31 | View |
| Feb 03, 2025 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 2.41K | $32.40 | -$45.56K | GRANT | 2.50% | 99.08K | Jan 30 - Jan 31 | View |
| Feb 03, 2025 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 2.28K | $32.46 | -$43.08K | GRANT | 2.51% | 93.15K | Jan 30 - Jan 31 | View |
| Jan 17, 2025 | Eric Swayze | EVP RESEARCH | 11.98K | $32.84 | -$235.68K | SELL-OPTIONS | ∞ | 184.00 | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 10.85K | $32.79 | -$213.89K | SELL-OPTIONS | 22.76% | 58.51K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 12.33K | $32.83 | -$241.63K | SELL-OPTIONS | 25.23% | 61.20K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 40.00K | $32.63 | -$1.09M | SELL-OPTIONS | 23.90% | 207.40K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Elizabeth L Hougen | EVP, FINANCE & CFO | 15.02K | $32.81 | -$290.99K | SELL-OPTIONS | 16.17% | 107.89K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 11.83K | $32.86 | -$232.41K | SELL-OPTIONS | 13.94% | 96.66K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Shannon L Devers | EVP, CHIEF HUMAN RESOURCES OFC | 8.03K | $32.78 | -$139.86K | SELL-OPTIONS | 101.50% | 15.94K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Brian Birchler | EVP, CORP AND DEVELOPMENT OPS | 8.88K | $32.70 | -$176.58K | SELL-OPTIONS | 19.24% | 55.05K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 11.26K | $32.90 | -$222.11K | SELL-OPTIONS | 14.14% | 90.87K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 6.82K | $32.70 | -$144.86K | SELL-OPTIONS | ∞ | 3.07K | Jan 15 - Jan 16 | View |
| Dec 26, 2024 | Michael R Hayden | DIRECTOR | 5.00K | $36.22 | $181.08K | BUY | 15.52% | 37.22K | Dec 23 | View |
| Nov 14, 2024 | Eric Swayze | EVP RESEARCH | -1.19K | $37.92 | -$45.28K | SELL | -3.41% | 33.87K | Nov 12 | View |
| Nov 14, 2024 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -6.63K | $38.05 | -$252.29K | SELL | -3.81% | 167.39K | Nov 12 | View |
| Nov 14, 2024 | Joseph Loscalzo | DIRECTOR | -13.51K | $37.86 | -$511.43K | SELL | -29.52% | 32.25K | Nov 12 | View |
| Oct 17, 2024 | Eric Swayze | EVP RESEARCH | 72.00 | $38.31 | -$2.03K | SELL-OPTIONS | 0.21% | 35.06K | Oct 15 - Oct 16 | View |
| Sep 03, 2024 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | -651.00 | $49.40 | -$32.16K | SELL | -0.76% | 84.82K | Aug 28 - Aug 29 | View |
| Aug 06, 2024 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | -2.43K | $48.00 | -$116.64K | SELL | -2.76% | 85.51K | Aug 05 | View |
| Jul 17, 2024 | Joseph Klein III | DIRECTOR | 0.00 | $37.21 | -$306.96K | SELL-OPTIONS | 0.00% | 100.00 | Jul 16 | View |
| Jul 17, 2024 | Allene M Diaz | DIRECTOR | 3.04K | $49.49 | -$81.02K | SELL-OPTIONS | 23.98% | 15.72K | Jul 15 - Jul 16 | View |
| Jun 20, 2024 | Spencer R Berthelsen | DIRECTOR | 0.00 | $37.91 | -$76.16K | SELL-OPTIONS | 0.00% | 147.33K | Jun 17 | View |
| May 07, 2024 | Joseph Klein III | DIRECTOR | -6.00K | $42.71 | -$256.28K | SELL | -98.36% | 100.00 | May 03 | View |
| Apr 17, 2024 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 6.83K | $41.60 | -$166.64K | SELL-OPTIONS | 47.32% | 21.27K | Apr 15 - Apr 16 | View |
| Apr 17, 2024 | Brian Birchler | EVP, CORP AND DEVELOPMENT OPS | 970.00 | $41.66 | -$37.70K | SELL-OPTIONS | 2.15% | 46.16K | Apr 15 - Apr 16 | View |
| Feb 16, 2024 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -387.00 | $44.49 | -$17.22K | SELL | -0.22% | 173.75K | Feb 16 | View |
| Feb 02, 2024 | Eric Swayze | EVP RESEARCH | -8.96K | $51.63 | -$654.71K | SELL | -20.67% | 34.41K | Jan 31 - Feb 02 | View |
| Feb 02, 2024 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 1.96K | $49.59 | -$102.70K | GRANT | 4.10% | 49.81K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 1.86K | $49.67 | -$97.41K | GRANT | 3.97% | 48.66K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 22.29K | $49.37 | -$1.16M | GRANT | 14.68% | 174.14K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Elizabeth L Hougen | EVP, FINANCE & CFO | 2.02K | $49.54 | -$105.27K | GRANT | 2.22% | 92.91K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 1.86K | $50.04 | -$98.13K | GRANT | 2.17% | 87.33K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Onaiza Cadoret-Manier | EVP, CHF GL PDT STR & OPER OFC | 2.02K | $49.60 | -$105.40K | GRANT | 5.96% | 35.83K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 1.76K | $49.52 | -$91.75K | GRANT | 2.27% | 79.08K | Feb 01 - Feb 02 | View |
| Jan 29, 2024 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -2.29K | $51.75 | -$118.25K | SELL | -1.48% | 151.85K | Jan 25 | View |
| Jan 29, 2024 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | -6.45K | $51.75 | -$333.79K | SELL | -12.11% | 46.80K | Jan 25 | View |
| Jan 18, 2024 | Onaiza Cadoret-Manier | EVP, CHF GL PDT STR & OPER OFC | 9.50K | $50.42 | -$280.52K | SELL-OPTIONS | 39.07% | 33.81K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 12.90K | $50.42 | -$390.43K | SELL-OPTIONS | 31.96% | 53.25K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Brian Birchler | EVP, CORP AND DEVELOPMENT OPS | 7.58K | $50.42 | -$226.73K | SELL-OPTIONS | 20.50% | 44.58K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Eric Swayze | EVP RESEARCH | 10.79K | $50.42 | -$317.88K | SELL-OPTIONS | ∞ | 85.00 | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 9.68K | $50.42 | -$276.39K | SELL-OPTIONS | 25.36% | 47.85K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 36.02K | $50.42 | -$1.62M | SELL-OPTIONS | 30.50% | 154.14K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Elizabeth L Hougen | EVP, FINANCE & CFO | 13.80K | $50.42 | -$437.77K | SELL-OPTIONS | 17.91% | 90.89K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 12.51K | $50.42 | -$369.96K | SELL-OPTIONS | 17.15% | 85.47K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 11.57K | $50.42 | -$340.06K | SELL-OPTIONS | 17.59% | 77.32K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 3.02K | $50.42 | -$102.04K | SELL-OPTIONS | ∞ | 1.64K | Jan 16 - Jan 17 | View |
| Jan 17, 2024 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 0.00 | $43.05 | -$167.20K | SELL-OPTIONS | 0.00% | 38.17K | Jan 12 | View |
| Jan 02, 2024 | Eric Swayze | EVP RESEARCH | 0.00 | $48.76 | -$77.17K | SELL-OPTIONS | 0.00% | 32.59K | Dec 28 | View |
| Dec 28, 2023 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 0.00 | $49.40 | -$85.86K | SELL-OPTIONS | 0.00% | 40.35K | Dec 26 | View |
| Dec 28, 2023 | B. Lynne Parshall | DIRECTOR | 0.00 | $48.91 | -$369.15K | SELL-OPTIONS | 0.00% | 82.59K | Dec 26 - Dec 28 | View |
| Dec 28, 2023 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 0.00 | $49.40 | -$103.08K | SELL-OPTIONS | 0.00% | 36.05K | Dec 26 | View |
| Dec 22, 2023 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $48.36 | -$46.36K | SELL-OPTIONS | 0.00% | 65.75K | Dec 20 - Dec 21 | View |
| Dec 22, 2023 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 0.00 | $48.42 | -$22.95K | SELL-OPTIONS | 0.00% | 72.96K | Dec 20 - Dec 21 | View |
| Dec 22, 2023 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 0.00 | $48.36 | -$49.06K | SELL-OPTIONS | 0.00% | 118.11K | Dec 20 - Dec 21 | View |
| Dec 18, 2023 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 0.00 | $48.46 | -$53.86K | SELL-OPTIONS | 0.00% | 118.11K | Dec 14 | View |
| Dec 18, 2023 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 0.00 | $48.46 | -$23.82K | SELL-OPTIONS | 0.00% | 72.96K | Dec 14 | View |
| Dec 18, 2023 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $48.46 | -$50.74K | SELL-OPTIONS | 0.00% | 65.75K | Dec 14 | View |
| Nov 17, 2023 | Joseph Klein III | DIRECTOR | -2.00K | $50.00 | -$100.00K | SELL | -8.21% | 22.35K | Nov 15 | View |
| Oct 18, 2023 | Eric Swayze | EVP RESEARCH | 73.00 | $47.95 | -$2.49K | SELL-OPTIONS | 0.22% | 32.59K | Oct 16 - Oct 17 | View |
| Oct 16, 2023 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -3.77K | $46.00 | -$173.42K | SELL | -3.09% | 118.11K | Oct 12 | View |
| Sep 29, 2023 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | -4.46K | $46.50 | -$207.39K | SELL | -6.35% | 65.75K | Sep 28 | View |
| Sep 28, 2023 | B. Lynne Parshall | DIRECTOR | -10.00K | $45.13 | -$451.27K | SELL | -10.80% | 82.59K | Sep 26 | View |
| Sep 28, 2023 | Joseph Klein III | DIRECTOR | -2.00K | $45.13 | -$90.25K | SELL | -7.59% | 24.35K | Sep 26 | View |
| Aug 03, 2023 | Allene M Diaz | DIRECTOR | -657.00 | $41.05 | -$26.97K | SELL | -4.93% | 12.68K | Aug 01 | View |
| Jul 19, 2023 | Joseph Klein III | DIRECTOR | 3.56K | $42.00 | -$149.31K | SELL-OPTIONS | 15.60% | 26.35K | Jul 17 - Jul 18 | View |
| Jul 11, 2023 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -18.65K | $42.25 | -$787.95K | SELL | -13.29% | 121.72K | Jul 07 | View |
| May 24, 2023 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | -1.53K | $41.70 | -$63.68K | SELL | -3.65% | 40.35K | May 24 | View |
| May 24, 2023 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -4.93K | $40.14 | -$197.91K | SELL | -3.39% | 140.37K | May 22 | View |
| Apr 19, 2023 | Brian Birchler | EVP, CORP AND DEVELOPMENT OPS | 1.20K | $36.50 | -$24.53K | SELL-OPTIONS | 3.41% | 36.53K | Apr 17 - Apr 18 | View |
| Apr 19, 2023 | Onaiza Cadoret-Manier | EVP, CHF GL PDT STR & OPER OFC | 3.08K | $36.50 | -$94.25K | SELL-OPTIONS | 14.53% | 24.31K | Apr 17 - Apr 18 | View |
| Apr 19, 2023 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 6.96K | $36.50 | -$141.63K | SELL-OPTIONS | 155.87% | 11.42K | Apr 17 - Apr 18 | View |
| Feb 07, 2023 | Eric Swayze | EVP RESEARCH | 1.90K | $40.79 | -$74.03K | GRANT | 6.32% | 31.94K | Feb 03 - Feb 06 | View |
| Feb 07, 2023 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 2.62K | $40.67 | -$57.46K | GRANT | 11.74% | 24.95K | Feb 03 - Feb 06 | View |
| Feb 07, 2023 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 1.90K | $40.86 | -$78.46K | GRANT | 4.79% | 41.58K | Feb 03 - Feb 06 | View |
| Feb 07, 2023 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 24.44K | $40.69 | -$1.00M | GRANT | 20.22% | 145.31K | Feb 03 - Feb 06 | View |
| Feb 07, 2023 | Elizabeth L Hougen | EVP, FINANCE & CFO | 2.06K | $40.59 | -$84.39K | GRANT | 2.81% | 75.50K | Feb 03 - Feb 06 | View |
| Feb 07, 2023 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 1.90K | $40.66 | -$78.07K | GRANT | 2.70% | 72.39K | Feb 03 - Feb 06 | View |
| Feb 07, 2023 | Onaiza Cadoret-Manier | EVP, CHF GL PDT STR & OPER OFC | 2.69K | $40.66 | -$59.00K | GRANT | 14.51% | 21.23K | Feb 03 - Feb 06 | View |
| Feb 07, 2023 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 1.80K | $40.57 | -$73.56K | GRANT | 2.65% | 69.65K | Feb 03 - Feb 06 | View |
| Feb 02, 2023 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | -9.00K | $39.56 | -$356.07K | SELL | -18.49% | 39.68K | Jan 30 - Jan 31 | View |
| Jan 19, 2023 | Eric Swayze | EVP RESEARCH | 10.15K | $39.74 | -$223.80K | SELL-OPTIONS | 51.02% | 30.04K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 8.29K | $39.57 | -$188.05K | SELL-OPTIONS | 59.11% | 22.33K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 14.04K | $39.49 | -$309.48K | SELL-OPTIONS | 40.51% | 48.68K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 32.20K | $39.49 | -$989.95K | SELL-OPTIONS | 36.32% | 120.86K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | Elizabeth L Hougen | EVP, FINANCE & CFO | 14.87K | $39.70 | -$328.72K | SELL-OPTIONS | 25.40% | 73.44K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 14.11K | $39.57 | -$311.53K | SELL-OPTIONS | 25.03% | 70.48K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | Onaiza Cadoret-Manier | EVP, CHF GL PDT STR & OPER OFC | 6.45K | $39.55 | -$148.22K | SELL-OPTIONS | 53.35% | 18.54K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 12.44K | $38.89 | -$271.36K | SELL-OPTIONS | 22.45% | 67.86K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 529.00 | $39.79 | -$14.92K | SELL-OPTIONS | 13.44% | 4.46K | Jan 17 - Jan 18 | View |
| Jan 18, 2023 | Joseph Klein III | DIRECTOR | -2.00K | $40.00 | -$80.00K | SELL | -8.07% | 22.79K | Jan 17 | View |
| Sep 12, 2022 | Eric Swayze | EVP RESEARCH | -460.00 | $44.55 | -$20.49K | SELL | -2.26% | 19.89K | Sep 08 | View |
| Aug 09, 2022 | Eric Swayze | EVP RESEARCH | -1.00 | $45.20 | -$45.20 | SELL | -0.00% | 20.35K | Aug 05 | View |
| Jul 19, 2022 | Joseph Klein III | DIRECTOR | 6.67K | $38.24 | -$50.98K | SELL-OPTIONS | 36.77% | 24.79K | Jul 15 | View |
| Apr 25, 2022 | Eric Swayze | EVP RESEARCH | -378.00 | $44.15 | -$16.69K | SELL | -1.82% | 20.35K | Apr 21 | View |
| Apr 14, 2022 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | -6.79K | $40.06 | -$272.06K | SELL | -16.43% | 34.54K | Apr 12 | View |
| Apr 05, 2022 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -355.00 | $37.49 | -$13.31K | SELL | -0.40% | 88.66K | Apr 01 | View |
| Jul 19, 2021 | Joseph Klein III | DIRECTOR | 4.33K | $35.30 | -$152.99K | SELL-OPTIONS | 31.18% | 18.23K | Jul 15 | View |
| Jun 25, 2021 | Spencer R Berthelsen | DIRECTOR | 0.00 | $23.52 | -$426.60K | SELL-OPTIONS | 0.00% | 101.05K | Jun 23 | View |
| Jun 17, 2021 | Frederick T Muto | DIRECTOR | 0.00 | $22.97 | -$410.00K | SELL-OPTIONS | 0.00% | 31.68K | Jun 15 | View |
| Mar 02, 2021 | Brett Monia | CHIEF EXECUTIVE OFFICER | 11.00 | $49.41 | -$1.81K | ACQUISITION | 0.02% | 50.11K | Feb 26 - Mar 01 | View |
| Jan 28, 2021 | STANLEY CROOKE | EXEC CHAIRMAN THE BOARD | -28.33K | $63.74 | -$1.81M | SELL | -5.40% | 496.41K | Jan 26 | View |
| Jan 27, 2021 | Patrick R. O'Neil | EVP & GENERAL COUNSEL | -5.32K | $63.50 | -$338.07K | SELL | -16.73% | 26.50K | Jan 25 | View |
| Jan 25, 2021 | STANLEY CROOKE | EXEC CHAIRMAN THE BOARD | -75.00K | $61.45 | -$4.61M | SELL | -13.10% | 497.50K | Jan 21 - Jan 22 | View |
| Jan 15, 2021 | Richard Geary | EVP, CHIEF DEVELOPMENT OFFC | -141.00 | $59.50 | -$8.39K | SELL | -0.46% | 30.31K | Jan 13 | View |
| Jan 06, 2021 | Eric Swayze | EVP, RESEARCH | -195.00 | $55.99 | -$10.92K | SELL | -3.68% | 5.11K | Jan 05 | View |
| Dec 28, 2020 | LYNNE PARSHALL | — | -10.00K | $60.00 | -$600.00K | SELL | -14.82% | 57.46K | Dec 23 | View |
| Dec 17, 2020 | STANLEY CROOKE | — | -40.41K | $49.80 | -$2.01M | SELL | -94.85% | 2.19K | Dec 15 - Dec 17 | View |
| Dec 09, 2020 | STANLEY CROOKE | — | -11.00K | $51.67 | -$568.35K | SELL | -1.69% | 640.97K | Dec 07 | View |
| Dec 08, 2020 | Brett Monia | — | 0.00 | $45.45 | -$266.29K | OPTION EXERCISE | 0.00% | 28.88K | Dec 04 | View |
| Dec 08, 2020 | FRANK BENNETT | — | 0.00 | $45.45 | -$88.77K | OPTION EXERCISE | 0.00% | 32.48K | Dec 04 | View |
| Dec 04, 2020 | FRANK BENNETT | — | 0.00 | $45.59 | -$80.76K | OPTION EXERCISE | 0.00% | 32.48K | Dec 02 | View |
| Dec 04, 2020 | Brett Monia | — | 0.00 | $45.59 | -$242.28K | OPTION EXERCISE | 0.00% | 28.88K | Dec 02 | View |
| Nov 30, 2020 | ELIZABETH HOUGEN | — | 0.00 | $44.96 | -$220.70K | OPTION EXERCISE | 0.00% | 32.49K | Nov 25 | View |
| Nov 30, 2020 | STANLEY CROOKE | — | 0.00 | $44.96 | -$132.24K | OPTION EXERCISE | 0.00% | 652.41K | Nov 25 | View |
| Nov 30, 2020 | Richard Geary | — | 0.00 | $44.96 | -$121.35K | OPTION EXERCISE | 0.00% | 30.45K | Nov 25 | View |
| Nov 30, 2020 | LYNNE PARSHALL | — | 0.00 | $44.96 | -$36.55K | OPTION EXERCISE | 0.00% | 67.46K | Nov 25 | View |
| Nov 25, 2020 | STANLEY CROOKE | — | 0.00 | $45.05 | -$152.24K | OPTION EXERCISE | 0.00% | 652.41K | Nov 23 - Nov 24 | View |
| Nov 25, 2020 | ELIZABETH HOUGEN | — | 0.00 | $45.06 | -$241.91K | OPTION EXERCISE | 0.00% | 32.49K | Nov 23 - Nov 24 | View |
| Nov 25, 2020 | Richard Geary | — | 0.00 | $45.06 | -$135.65K | OPTION EXERCISE | 0.00% | 30.45K | Nov 23 - Nov 24 | View |
| Nov 25, 2020 | LYNNE PARSHALL | — | 0.00 | $45.06 | -$40.57K | OPTION EXERCISE | 0.00% | 67.46K | Nov 23 - Nov 24 | View |
| Nov 05, 2020 | FRANK BENNETT | — | 0.00 | $43.32 | -$103.55K | OPTION EXERCISE | 0.00% | 32.48K | Nov 03 | View |
| Oct 22, 2020 | JOSEPH KLEIN III | — | -2.89K | $46.86 | -$135.39K | SELL | -17.21% | 13.89K | Oct 20 | View |
| Sep 23, 2020 | STANLEY CROOKE | — | -52.00K | $50.40 | -$2.62M | SELL | -7.38% | 652.41K | Sep 21 - Sep 22 | View |
| Sep 02, 2020 | Brett Monia | — | -78.00 | $49.08 | -$6.37K | ACQUISITION OR DISPOSITION | -0.27% | 28.88K | Aug 31 - Sep 01 | View |
| Jun 29, 2020 | Breaux Castleman | — | 0.00 | $43.33 | -$333.40K | OPTION EXERCISE | 0.00% | 15.18K | Jun 25 | View |
| Jun 29, 2020 | FRANK BENNETT | — | 0.00 | $49.82 | -$298.45K | OPTION EXERCISE | 0.00% | 32.36K | Jun 25 | View |
| Jun 26, 2020 | STANLEY CROOKE | — | -14.91K | $59.67 | -$889.91K | SELL | -2.08% | 702.41K | Jun 24 - Jun 25 | View |
| Jun 25, 2020 | SPENCER BERTHELSEN | — | 0.00 | $33.99 | -$743.10K | OPTION EXERCISE | 0.00% | 97.05K | Jun 23 | View |
| Jun 19, 2020 | STANLEY CROOKE | — | -27.00K | $58.08 | -$1.57M | SELL | -3.63% | 717.33K | Jun 17 - Jun 19 | View |
| Mar 27, 2020 | STANLEY CROOKE | — | -16.00K | $47.00 | -$752.00K | SELL | -2.22% | 705.97K | Mar 25 | View |
| Mar 23, 2020 | STANLEY CROOKE | — | -16.00K | $45.16 | -$722.55K | SELL | -2.21% | 706.97K | Mar 19 | View |
| Mar 19, 2020 | STANLEY CROOKE | — | -20.39K | $44.75 | -$912.36K | SELL | -2.57% | 771.94K | Mar 17 | View |
| Feb 11, 2020 | Patrick R. O'Neil | — | -3.88K | $59.60 | -$231.37K | SELL | -15.78% | 20.72K | Feb 10 | View |
| Jan 03, 2020 | Brett Monia | — | -173.00 | $60.25 | -$10.42K | SELL | -1.05% | 16.29K | Jan 02 | View |
| Dec 23, 2019 | JOSEPH KLEIN III | DIRECTOR | 0.00 | $48.70 | -$26.34K | SELL-OPTIONS | 0.00% | 12.78K | Dec 23 | View |
| Dec 18, 2019 | JOSEPH KLEIN III | DIRECTOR | 0.00 | $50.49 | -$29.92K | SELL-OPTIONS | 0.00% | 12.78K | Dec 16 | View |
| Dec 10, 2019 | JOSEPH KLEIN III | DIRECTOR | 0.00 | $49.64 | -$28.21K | SELL-OPTIONS | 0.00% | 12.78K | Dec 09 | View |
| Dec 05, 2019 | ELIZABETH HOUGEN | SVP, FINANCE & CFO | 0.00 | $37.91 | -$247.39K | SELL-OPTIONS | 0.00% | 20.05K | Dec 04 | View |
| Dec 05, 2019 | Richard Geary | SVP, DEVELOPMENT | 0.00 | $39.84 | -$503.10K | SELL-OPTIONS | 0.00% | 21.58K | Dec 04 | View |
| Dec 04, 2019 | JOSEPH KLEIN III | DIRECTOR | 0.00 | $49.81 | -$28.55K | SELL-OPTIONS | 0.00% | 12.78K | Dec 02 | View |
| Dec 04, 2019 | Richard Geary | SVP, DEVELOPMENT | 0.00 | $39.87 | -$251.84K | SELL-OPTIONS | 0.00% | 21.58K | Dec 02 | View |
| Nov 26, 2019 | JOSEPH KLEIN III | DIRECTOR | -812.00 | $62.90 | -$51.07K | SELL | -5.97% | 12.78K | Nov 25 | View |
| Nov 26, 2019 | ELIZABETH HOUGEN | SVP, FINANCE & CFO | 0.00 | $36.66 | -$206.72K | SELL-OPTIONS | 0.00% | 20.05K | Nov 25 | View |
| Nov 21, 2019 | JOSEPH KLEIN III | DIRECTOR | -2.00K | $60.00 | -$120.00K | SELL | -12.82% | 13.60K | Nov 20 | View |
| Nov 21, 2019 | Brett Monia | COO & SVP, TRANSLATIONAL MED | -5.78K | $60.01 | -$346.62K | SELL | -25.98% | 16.46K | Nov 20 | View |
| Nov 21, 2019 | ELIZABETH HOUGEN | SVP, FINANCE & CFO | 0.00 | $34.81 | -$191.92K | SELL-OPTIONS | 0.00% | 20.05K | Nov 19 | View |
| Aug 22, 2019 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $55.70 | -$696.36K | SELL-OPTIONS | 0.00% | 795.02K | Aug 20 - Aug 21 | View |
| Jul 22, 2019 | STANLEY CROOKE | CHAIRMAN & CEO | 0.00 | $55.06 | -$303.81K | SELL-OPTIONS | 0.00% | 795.02K | Jul 18 | View |
| Jul 02, 2019 | Brett Monia | CHIEF OPERATING OFFICER | -37.00 | $56.05 | -$6.04K | SELL | -0.17% | 22.23K | Jul 01 - Jul 02 | View |
| Jun 26, 2019 | SPENCER BERTHELSEN | DIRECTOR | 0.00 | $40.00 | -$710.31K | SELL-OPTIONS | 0.00% | 94.16K | Jun 24 | View |
| Jun 06, 2019 | FREDERICK MUTO | DIRECTOR | 0.00 | $40.81 | -$734.55K | SELL-OPTIONS | 0.00% | 11.29K | Jun 04 | View |
| May 08, 2019 | FREDERICK MUTO | DIRECTOR | 0.00 | $48.59 | -$386.64K | SELL-OPTIONS | 0.00% | 11.29K | May 06 | View |
| May 01, 2019 | LYNNE PARSHALL | DIRECTOR | 0.00 | $57.44 | -$1.76M | SELL-OPTIONS | 0.00% | 52.68K | Apr 29 | View |
| Apr 17, 2019 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $55.20 | -$1.90M | SELL-OPTIONS | 0.00% | 730.92K | Apr 15 - Apr 16 | View |
| Apr 10, 2019 | Richard Geary | SVP, DEVELOPMENT | 0.00 | $63.27 | -$1.92M | SELL-OPTIONS | 0.00% | 21.44K | Apr 08 | View |
| Apr 05, 2019 | Patrick R. O'Neil | SVP LEGAL & GENERAL COUNSEL | -3.00K | $70.90 | -$1.47M | SELL | -15.25% | 16.67K | Apr 03 - Apr 05 | View |
| Mar 20, 2019 | Patrick R. O'Neil | SVP LEGAL & GENERAL COUNSEL | 0.00 | $70.18 | -$495.97K | SELL-OPTIONS | 0.00% | 19.67K | Mar 18 | View |
| Mar 20, 2019 | JOSEPH WENDER | DIRECTOR | -10.00K | $79.63 | -$796.26K | SELL | -14.51% | 58.92K | Mar 19 | View |
| Mar 14, 2019 | LYNNE PARSHALL | DIRECTOR | 0.00 | $57.44 | -$292.77K | SELL-OPTIONS | 0.00% | 52.68K | Mar 12 | View |
| Mar 01, 2019 | LYNNE PARSHALL | DIRECTOR | 0.00 | $54.94 | -$251.07K | SELL-OPTIONS | 0.00% | 52.68K | Feb 27 | View |
| Mar 01, 2019 | Patrick R. O'Neil | SVP LEGAL & GENERAL COUNSEL | 0.00 | $56.56 | -$613.63K | SELL-OPTIONS | 0.00% | 19.67K | Feb 27 | View |
| Feb 27, 2019 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $50.32 | -$1.61M | SELL-OPTIONS | 0.00% | 795.02K | Feb 25 - Feb 26 | View |
| Feb 14, 2019 | Patrick R. O'Neil | SVP LEGAL & GENERAL COUNSEL | 0.00 | $49.69 | -$5.40K | SELL-OPTIONS | 0.00% | 19.67K | Feb 12 | View |
| Feb 14, 2019 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $49.48 | -$994.80K | SELL-OPTIONS | 0.00% | 730.92K | Feb 13 | View |
| Feb 14, 2019 | Richard Geary | SVP, DEVELOPMENT | -999.00 | $60.00 | -$59.94K | SELL | -4.45% | 21.44K | Feb 13 | View |
| Feb 05, 2019 | Patrick R. O'Neil | SVP LEGAL & GENERAL COUNSEL | 0.00 | $49.56 | -$379.91K | SELL-OPTIONS | 0.00% | 19.67K | Feb 01 - Feb 05 | View |
| Feb 05, 2019 | FRANK BENNETT | SVP, ANTISENSE RESEARCH | 0.00 | $36.49 | -$392.97K | SELL-OPTIONS | 0.00% | 24.53K | Feb 01 | View |
| Jan 03, 2019 | Patrick R. O'Neil | SVP LEGAL & GENERAL COUNSEL | 66.00 | $46.01 | -$74.91K | SELL-OPTIONS | 0.45% | 14.58K | Jan 01 - Jan 03 | View |
| Jan 03, 2019 | Brett Monia | CHIEF OPERATING OFFICER | -4.00 | $44.97 | -$3.79K | SELL | -0.03% | 15.84K | Jan 01 - Jan 02 | View |
| Dec 20, 2018 | ELIZABETH HOUGEN | SVP, FINANCE & CFO | 0.00 | $29.64 | -$181.92K | SELL-OPTIONS | 0.00% | 14.77K | Dec 18 - Dec 19 | View |
| Nov 01, 2018 | FRANK BENNETT | SVP, ANTISENSE RESEARCH | 0.00 | $32.11 | -$435.62K | SELL-OPTIONS | 0.00% | 19.40K | Nov 01 | View |
| Aug 29, 2018 | Brett Monia | CHIEF OPERATING OFFICER | 0.00 | $30.62 | -$771.35K | SELL-OPTIONS | 0.00% | 15.84K | Aug 27 | View |
| Aug 09, 2018 | FRANK BENNETT | SVP, ANTISENSE RESEARCH | 0.00 | $29.84 | -$378.97K | SELL-OPTIONS | 0.00% | 19.40K | Aug 08 | View |
| Jul 25, 2018 | Brett Monia | CHIEF OPERATING OFFICER | -156.00 | $47.03 | -$7.34K | SELL | -0.98% | 15.84K | Jul 24 | View |
| Jun 25, 2018 | SPENCER BERTHELSEN | DIRECTOR | 0.00 | $28.09 | -$426.34K | SELL-OPTIONS | 0.00% | 91.50K | Jun 25 | View |
| May 31, 2018 | FREDERICK MUTO | DIRECTOR | 0.00 | $30.17 | -$488.55K | SELL-OPTIONS | 0.00% | 8.63K | May 31 | View |
| May 11, 2018 | FRANK BENNETT | SVP, ANTISENSE RESEARCH | 0.00 | $26.13 | -$471.88K | SELL-OPTIONS | 0.00% | 19.11K | May 11 | View |
| May 11, 2018 | JOSEPH WENDER | DIRECTOR | 0.00 | $29.59 | -$471.41K | SELL-OPTIONS | 0.00% | 72.50K | May 11 | View |
| Apr 19, 2018 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $28.99 | -$430.29K | SELL-OPTIONS | 0.00% | 729.52K | Apr 17 | View |
| Mar 30, 2018 | JOSEPH KLEIN III | DIRECTOR | 0.00 | $35.28 | -$43.46K | SELL-OPTIONS | 0.00% | 10.04K | Mar 29 | View |
| Mar 16, 2018 | JOSEPH KLEIN III | DIRECTOR | 0.00 | $37.77 | -$53.42K | SELL-OPTIONS | 0.00% | 10.04K | Mar 15 | View |
| Mar 13, 2018 | Patrick R. O'Neil | SVP LEGAL & GENERAL COUNSEL | 0.00 | $32.91 | -$44.18K | SELL-OPTIONS | 0.00% | 14.45K | Mar 12 | View |
| Mar 01, 2018 | JOSEPH KLEIN III | DIRECTOR | 0.00 | $43.72 | -$49.14K | SELL-OPTIONS | 0.00% | 10.04K | Feb 28 | View |
| Feb 16, 2018 | JOSEPH KLEIN III | DIRECTOR | 0.00 | $42.26 | -$40.39K | SELL-OPTIONS | 0.00% | 10.04K | Feb 15 | View |
| Jan 31, 2018 | Patrick R. O'Neil | SVP LEGAL & GENERAL COUNSEL | 0.00 | $32.91 | -$15.68K | SELL-OPTIONS | 0.00% | 14.45K | Jan 29 | View |
| Jan 29, 2018 | Patrick R. O'Neil | SVP LEGAL & GENERAL COUNSEL | 0.00 | $32.91 | -$28.50K | SELL-OPTIONS | 0.00% | 14.45K | Jan 25 | View |
| Jan 17, 2018 | ELIZABETH HOUGEN | SVP, FINANCE & CFO | 4.01K | $51.76 | -$140.99K | SELL-OPTIONS | 38.20% | 14.50K | Jan 15 - Jan 16 | View |
| Jan 17, 2018 | JOSEPH KLEIN III | DIRECTOR | 0.00 | $44.03 | -$50.98K | SELL-OPTIONS | 0.00% | 10.04K | Jan 16 | View |
| Jan 17, 2018 | Richard Geary | SVP, DEVELOPMENT | 4.01K | $51.76 | -$140.94K | SELL-OPTIONS | 31.64% | 16.68K | Jan 15 - Jan 16 | View |
| Jan 17, 2018 | B. Lynne Parshall attorney-in-fact | DIRECTOR | 12.35K | $51.76 | -$309.84K | SELL-OPTIONS | 47.83% | 38.18K | Jan 15 - Jan 16 | View |
| Jan 17, 2018 | PATRICK ONEIL | SVP, LEGAL & GENERAL COUNSEL | 3.97K | $51.76 | -$139.60K | SELL-OPTIONS | 37.82% | 14.45K | Jan 15 - Jan 16 | View |
| Jan 17, 2018 | Sarah Boyce | CHIEF BUSINESS OFFICER | 3.17K | $51.76 | -$113.66K | SELL-OPTIONS | 55.05% | 8.93K | Jan 15 - Jan 16 | View |
| Jan 17, 2018 | FRANK BENNETT | SVP, ANTISENSE RESEARCH | 3.97K | $51.76 | -$139.54K | SELL-OPTIONS | 26.19% | 19.11K | Jan 15 - Jan 16 | View |
| Jan 17, 2018 | STANLEY CROOKE | CHAIRMAN AND CEO | 14.79K | $51.76 | -$856.58K | SELL-OPTIONS | 2.07% | 729.52K | Jan 15 | View |
| Jan 17, 2018 | Brett Monia | COO | 4.16K | $51.76 | -$146.01K | SELL-OPTIONS | 35.84% | 15.78K | Jan 15 - Jan 16 | View |
| Jan 10, 2018 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $33.17 | -$414.39K | SELL-OPTIONS | 0.00% | 728.45K | Jan 08 | View |
| Jan 05, 2018 | Stanley T Crooke | CHAIRMAN AND CEO | 0.00 | $32.10 | -$787.95K | SELL-OPTIONS | 0.00% | 728.45K | Jan 03 | View |
| Jan 02, 2018 | Brett Monia | SVP, ANTISENSE DRUG DISCOVERY | -7.00 | $46.38 | -$1.48K | SELL | -0.06% | 11.62K | Jan 01 - Jan 02 | View |
| Jan 02, 2018 | JOSEPH KLEIN III | DIRECTOR | 0.00 | $39.52 | -$66.27K | SELL-OPTIONS | 0.00% | 10.04K | Dec 29 | View |
| Dec 19, 2017 | JOSEPH KLEIN III | DIRECTOR | 0.00 | $40.08 | -$69.66K | SELL-OPTIONS | 0.00% | 10.04K | Dec 15 | View |
| Dec 19, 2017 | Elizabeth L Hougen | SVP, FINANCE & CFO | 0.00 | $31.42 | -$211.30K | SELL-OPTIONS | 0.00% | 10.39K | Dec 15 | View |
| Dec 06, 2017 | Elizabeth L Hougen | SVP, FINANCE & CFO | 0.00 | $33.64 | -$186.84K | SELL-OPTIONS | 0.00% | 10.39K | Dec 04 | View |
| Dec 01, 2017 | Elizabeth L Hougen | SVP, FINANCE & CFO | 0.00 | $31.66 | -$256.38K | SELL-OPTIONS | 0.00% | 10.39K | Nov 29 | View |
| Dec 01, 2017 | JOSEPH KLEIN III | DIRECTOR | 0.00 | $41.01 | -$75.24K | SELL-OPTIONS | 0.00% | 10.04K | Nov 30 | View |
| Dec 01, 2017 | PATRICK ONEIL | SVP, LEGAL & GENERAL COUNSEL | 0.00 | $33.16 | -$44.68K | SELL-OPTIONS | 0.00% | 10.43K | Dec 01 | View |
| Nov 17, 2017 | Elizabeth L Hougen | SVP, FINANCE & CFO | 0.00 | $32.32 | -$308.42K | SELL-OPTIONS | 0.00% | 10.39K | Nov 16 | View |
| Nov 17, 2017 | JOSEPH KLEIN III | DIRECTOR | 2.81K | $36.70 | -$20.07K | SELL-OPTIONS | 38.91% | 10.04K | Nov 15 - Nov 16 | View |
| Nov 14, 2017 | JOSEPH KLEIN III | DIRECTOR | -3.00K | $55.39 | -$166.17K | SELL | -29.33% | 7.23K | Nov 13 | View |
| Nov 03, 2017 | PATRICK ONEIL | SVP, LEGAL & GENERAL COUNSEL | 0.00 | $34.59 | -$47.53K | SELL-OPTIONS | 0.00% | 10.43K | Nov 01 | View |
| Oct 20, 2017 | FRANK BENNETT | SVP, ANTISENSE RESEARCH | 0.00 | $37.64 | -$670.20K | SELL-OPTIONS | 0.00% | 15.04K | Oct 18 | View |
| Oct 20, 2017 | B. Lynne Parshall | COO | 0.00 | $46.35 | -$601.07K | SELL-OPTIONS | 0.00% | 25.74K | Oct 18 | View |
| Oct 17, 2017 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $36.74 | -$749.87K | SELL-OPTIONS | 0.00% | 728.45K | Oct 13 | View |
| Oct 17, 2017 | Richard Geary | SVP, DEVELOPMENT | -807.00 | $33.71 | -$440.69K | SELL | -6.13% | 12.35K | Oct 13 | View |
| Oct 06, 2017 | Patrick R. O'Neil | SVP, LEGAL & GENERAL COUNSEL | 0.00 | $32.55 | -$44.89K | SELL-OPTIONS | 0.00% | 10.43K | Oct 05 | View |
| Oct 04, 2017 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $33.45 | -$1.07M | SELL-OPTIONS | 0.00% | 728.45K | Oct 02 - Oct 04 | View |
| Sep 07, 2017 | Patrick R. O'Neil | SVP, LEGAL AND GENERAL COUNSEL | 0.00 | $31.13 | -$47.75K | SELL-OPTIONS | 0.00% | 10.43K | Sep 05 - Sep 06 | View |
| Jul 26, 2017 | FRANK BENNETT | SVP, ANTISENSE RESEARCH | 0.00 | $34.79 | -$490.00K | SELL-OPTIONS | 0.00% | 15.04K | Jul 24 | View |
| Jul 24, 2017 | Stanley T Crooke | CHAIRMAN AND CEO | 0.00 | $34.68 | -$454.70K | SELL-OPTIONS | 0.00% | 728.45K | Jul 20 | View |
| Jul 18, 2017 | Stanley T Crooke | CHAIRMAN AND CEO | 0.00 | $33.23 | -$634.20K | SELL-OPTIONS | 0.00% | 728.45K | Jul 17 | View |
| Jul 03, 2017 | Brett Monia | SVP, ANTISENSE DRUG DISCOVERY | -146.00 | $46.00 | -$9.24K | SELL | -1.24% | 11.63K | Jul 01 - Jul 03 | View |
| Jul 03, 2017 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $30.02 | -$728.62K | SELL-OPTIONS | 0.00% | 728.45K | Jul 03 | View |
| Jun 02, 2017 | FREDERICK MUTO | DIRECTOR | 0.00 | $27.49 | -$443.13K | SELL-OPTIONS | 0.00% | 6.16K | May 31 | View |
| Jun 02, 2017 | Patrick R. O'Neil | SVP, LEGAL & GENERAL COUNSEL | 0.00 | $29.41 | -$2.60K | SELL-OPTIONS | 0.00% | 10.30K | Jun 01 | View |
| May 03, 2017 | Patrick R. O'Neil | SVP, LEGAL & GENERAL COUNSEL | -150.00 | $29.79 | -$26.28K | SELL | -1.44% | 10.30K | May 01 | View |
| Apr 27, 2017 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $27.53 | -$669.24K | SELL-OPTIONS | 0.00% | 728.45K | Apr 25 | View |
| Apr 26, 2017 | Patrick R. O'Neil | SVP, LEGAL & GENERAL COUNSEL | 0.00 | $27.91 | -$17.09K | SELL-OPTIONS | 0.00% | 10.45K | Apr 24 | View |
| Apr 21, 2017 | Stanley T Crooke | CHAIRMAN AND CEO | 0.00 | $25.25 | -$198.00K | SELL-OPTIONS | 0.00% | 728.45K | Apr 19 | View |
| Apr 13, 2017 | Patrick R. O'Neil | SVP, LEGAL & GENERAL COUNSEL | -1.00K | $40.07 | -$40.07K | SELL | -8.73% | 10.45K | Apr 12 | View |
| Apr 13, 2017 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $24.07 | -$731.01K | SELL-OPTIONS | 0.00% | 728.45K | Apr 12 - Apr 13 | View |
| Mar 06, 2017 | FRANK BENNETT | SVP, ANTISENSE RESEARCH | 0.00 | $32.64 | -$223.55K | SELL-OPTIONS | 0.00% | 14.79K | Mar 03 | View |
| Mar 06, 2017 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $29.29 | -$526.64K | SELL-OPTIONS | 0.00% | 728.45K | Mar 02 | View |
| Mar 02, 2017 | B. Lynne Parshall | COO | 0.00 | $31.97 | -$159.89K | SELL-OPTIONS | 0.00% | 25.65K | Mar 01 | View |
| Mar 02, 2017 | Patrick R. O'Neil | SVP, LEGAL & GENERAL COUNSEL | -1.00K | $30.05 | -$68.53K | SELL | -8.03% | 11.45K | Mar 01 | View |
| Feb 08, 2017 | Patrick R. O'Neil | SVP, LEGAL & GENERAL COUNSEL | -1.00K | $28.43 | -$63.91K | SELL | -7.44% | 12.45K | Feb 06 | View |
| Jan 18, 2017 | Sarah Boyce | CHIEF BUSINESS OFFICER | 2.12K | $46.29 | -$63.00K | SELL-OPTIONS | 67.80% | 5.25K | Jan 15 - Jan 17 | View |
| Jan 18, 2017 | Brett Monia | SVP, ANTISENSE DRUG DISCOVERY | 3.90K | $46.29 | -$115.82K | SELL-OPTIONS | 49.54% | 11.77K | Jan 15 - Jan 17 | View |
| Jan 18, 2017 | PATRICK ONEIL | SVP, LEGAL & GENERAL COUNSEL | 3.50K | $46.29 | -$103.97K | SELL-OPTIONS | 35.17% | 13.45K | Jan 15 - Jan 17 | View |
| Jan 18, 2017 | FRANK BENNETT | SVP, ANTISENSE RESEARCH | 3.77K | $46.29 | -$112.07K | SELL-OPTIONS | 34.27% | 14.79K | Jan 15 - Jan 17 | View |
| Jan 18, 2017 | STANLEY CROOKE | CHAIRMAN AND CEO | 13.88K | $46.29 | -$738.64K | SELL-OPTIONS | 1.94% | 728.45K | Jan 15 - Jan 17 | View |
| Jan 18, 2017 | B. Lynne Parshall attorney-in-fact | COO | 8.79K | $46.29 | -$335.41K | SELL-OPTIONS | 52.11% | 25.65K | Jan 15 - Jan 17 | View |
| Jan 18, 2017 | ELIZABETH HOUGEN | SVP, FINANCE & CFO | 3.54K | $46.29 | -$105.22K | SELL-OPTIONS | 52.48% | 10.29K | Jan 15 - Jan 17 | View |
| Jan 18, 2017 | Richard Geary | SVP, DEVELOPMENT | 3.81K | $46.29 | -$113.00K | SELL-OPTIONS | 41.55% | 12.96K | Jan 15 - Jan 17 | View |
| Jan 12, 2017 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $28.39 | -$550.75K | SELL-OPTIONS | 0.00% | 727.56K | Jan 10 | View |
| Jan 04, 2017 | Stanley T Crooke | CHAIRMAN AND CEO | 0.00 | $28.21 | -$773.58K | SELL-OPTIONS | 0.00% | 727.56K | Jan 03 - Jan 04 | View |
| Jan 04, 2017 | Brett P Monia | SVP, ANTISENSE DRUG DISCOVERY | 0.00 | $34.68 | -$8.60K | ACQ/DIS | 0.00% | 7.87K | Jan 01 - Jan 03 | View |
| Dec 20, 2016 | Brett Monia | SVP, ANTISENSE DRUG DISCOVERY | -130.00 | $52.48 | -$6.82K | SELL | -1.62% | 7.87K | Dec 20 | View |
| Dec 16, 2016 | B. Lynne Parshall | COO | 0.00 | $28.63 | -$171.00K | SELL-OPTIONS | 0.00% | 16.69K | Dec 15 | View |
| Dec 07, 2016 | Elizabeth Hougen | SVP, FINANCE & CFO | 0.00 | $28.66 | -$86.95K | SELL-OPTIONS | 0.00% | 6.55K | Dec 05 | View |
| Dec 07, 2016 | Patrick R. O'Neil | SVP, LEGAL & GENERAL COUNSEL | 0.00 | $27.91 | -$11.96K | SELL-OPTIONS | 0.00% | 9.53K | Dec 05 | View |
| Dec 02, 2016 | B. Lynne Parshall | COO | 0.00 | $28.46 | -$344.24K | SELL-OPTIONS | 0.00% | 16.69K | Dec 01 | View |
| Nov 16, 2016 | Elizabeth L Hougen | SVP, FINANCE & CFO | 0.00 | $29.38 | -$90.58K | SELL-OPTIONS | 0.00% | 6.55K | Nov 14 | View |
| Nov 14, 2016 | Patrick R. O'Neil | SVP, LEGAL & GENERAL COUNSEL | 0.00 | $27.91 | -$34.18K | SELL-OPTIONS | 0.00% | 9.53K | Nov 14 | View |
| Nov 14, 2016 | ELIZABETH HOUGEN | SVP, FINANCE & CFO | 0.00 | $25.51 | -$142.38K | SELL-OPTIONS | 0.00% | 6.55K | Nov 09 - Nov 11 | View |
| Nov 14, 2016 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $23.37 | -$947.07K | SELL-OPTIONS | 0.00% | 727.56K | Nov 09 - Nov 10 | View |
| Nov 14, 2016 | FRANK BENNETT | SVP, ANTISENSE RESEARCH | 0.00 | $24.42 | -$599.59K | SELL-OPTIONS | 0.00% | 10.80K | Nov 09 | View |
| Nov 09, 2016 | C. Frank Bennett | SVP, ANTISENSE RESEARCH | 0.00 | $22.63 | -$113.65K | SELL-OPTIONS | 0.00% | 10.80K | Nov 07 | View |
| Oct 07, 2016 | Stanley T Crooke | CHAIRMAN AND CEO | 0.00 | $23.45 | -$289.52K | SELL-OPTIONS | 0.00% | 727.56K | Oct 05 | View |
| Sep 29, 2016 | Stanley T Crooke | CHAIRMAN AND CEO | 0.00 | $23.16 | -$566.12K | SELL-OPTIONS | 0.00% | 727.56K | Sep 27 | View |
| Sep 23, 2016 | Stanley T Crooke | CHAIRMAN AND CEO | 0.00 | $22.89 | -$554.62K | SELL-OPTIONS | 0.00% | 727.56K | Sep 21 | View |
| Sep 06, 2016 | B. Lynne Parshall | COO | 0.00 | $19.65 | -$255.88K | SELL-OPTIONS | 0.00% | 16.69K | Sep 01 | View |
| Jun 02, 2016 | FREDERICK MUTO | DIRECTOR | 0.00 | $14.12 | -$204.78K | SELL-OPTIONS | 0.00% | 4.04K | May 31 | View |
| Apr 07, 2016 | PATRICK ONEIL | SVP, LEGAL & GENERAL COUNSEL | 0.00 | $27.91 | -$34.18K | SELL-OPTIONS | 0.00% | 9.12K | Apr 06 | View |
| Apr 07, 2016 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $28.21 | -$394.19K | SELL-OPTIONS | 0.00% | 727.56K | Apr 06 | View |
| Apr 01, 2016 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $25.49 | -$335.43K | SELL-OPTIONS | 0.00% | 727.56K | Mar 31 | View |
| Mar 24, 2016 | Patrick R. O'Neil | SVP, LEGAL & GENERAL COUNSEL | 0.00 | $28.11 | -$34.58K | SELL-OPTIONS | 0.00% | 9.12K | Mar 23 | View |
| Jan 19, 2016 | STANLEY CROOKE | CHAIRMAN AND CEO | 11.26K | $41.46 | -$555.60K | SELL-OPTIONS | 1.57% | 727.56K | Jan 15 - Jan 19 | View |
| Jan 19, 2016 | ELIZABETH HOUGEN | SVP, FINANCE & CFO | 2.86K | $41.46 | -$78.74K | SELL-OPTIONS | 82.55% | 6.33K | Jan 15 - Jan 19 | View |
| Jan 19, 2016 | PATRICK ONEIL | SVP, LEGAL & GENERAL COUNSEL | 2.82K | $41.46 | -$77.57K | SELL-OPTIONS | 44.78% | 9.12K | Jan 15 - Jan 19 | View |
| Jan 19, 2016 | B. Lynne Parshall | COO & SECRETARY | 8.07K | $41.46 | -$215.26K | SELL-OPTIONS | 98.30% | 16.29K | Jan 15 - Jan 19 | View |
| Jan 19, 2016 | Richard Geary | SVP, DEVELOPMENT | 3.27K | $41.46 | -$89.63K | SELL-OPTIONS | 64.16% | 8.35K | Jan 15 - Jan 19 | View |
| Jan 19, 2016 | Brett Monia | SVP, ANTISENSE DRUG DISCOVERY | 3.33K | $41.46 | -$91.54K | SELL-OPTIONS | 76.53% | 7.69K | Jan 15 - Jan 19 | View |
| Jan 19, 2016 | Sarah Boyce | CHIEF BUSINESS OFFICER | 1.32K | $41.46 | -$36.15K | SELL-OPTIONS | 314.08% | 1.74K | Jan 15 - Jan 19 | View |
| Jan 19, 2016 | FRANK BENNETT | SVP, ANTISENSE RESEARCH | 3.19K | $41.46 | -$87.47K | SELL-OPTIONS | 43.01% | 10.59K | Jan 15 - Jan 19 | View |
| Jan 07, 2016 | Stanley T Crooke | CHAIRMAN AND CEO | 0.00 | $36.15 | -$285.49K | SELL-OPTIONS | 0.00% | 726.69K | Jan 05 | View |
| Jan 04, 2016 | B. Lynne Parshall | COO & SECRETARY | 72.00 | $39.22 | -$34.07K | SELL-OPTIONS | 0.88% | 8.21K | Jan 01 - Jan 04 | View |
| Jan 04, 2016 | PATRICK ONEIL | SVP, LEGAL & GENERAL COUNSEL | 43.00 | $35.27 | -$51.26K | SELL-OPTIONS | 0.69% | 6.30K | Jan 01 - Jan 04 | View |
| Jan 04, 2016 | Brett Monia | SVP, ANTISENSE DRUG DISCOVERY | 3.00 | $54.36 | -$1.54K | ACQUISITION | 0.07% | 4.36K | Jan 01 - Jan 04 | View |
| Jan 04, 2016 | STANLEY CROOKE | CHAIRMAN AND CEO | 0.00 | $35.62 | -$559.43K | SELL-OPTIONS | 0.00% | 726.69K | Jan 04 | View |
よくある質問
Q
インサイダー取引は合法ですか？
A
インサイダー取引は、インサイダーがその取引をSECに報告する限り合法である。違法な証券取引は、インサイダーが受託者の義務に違反しているか、取引を報告していない場合に発生する。
Q
市場操作の例を教えてください。
A
インサイダー取引、パンプ・アンド・ダンプ・スキーム、フロント・ランニング、ウォッシュ・トレードはすべて市場操作の例である。インサイダーの資産の動きを追跡する投資家は、前進する前に、これらのインサイダーがなぜ株式を取引しているのかについて慎重に考えるべきである。
ブラウズ インサイダー取引 全銘柄の
IONS インサイダー取引ニュース
こんな人も見ています
© 2025 Benzinga | All Rights Reserved